ArthroCare Corp (ARTC)

48.60
0.04 0.08
NASDAQ : Health Care
Prev Close 48.56
Open 48.60
Day Low/High 48.56 / 48.61
52 Wk Low/High 31.56 / 49.95
Volume 916.44K
Avg Volume 553.60K
Exchange NASDAQ
Shares Outstanding 34.50M
Market Cap 1.68B
EPS 0.65
P/E Ratio 110.36
Div & Yield N.A. (N.A)
ArthroCare Reports First Quarter 2012 Financial Results

ArthroCare Reports First Quarter 2012 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.

ArthroCare Announces Date For First Quarter 2012 Financial Results Press Release And Conference Call

ArthroCare Announces Date For First Quarter 2012 Financial Results Press Release And Conference Call

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its first quarter 2012 results on Thursday, May 3, 2012.

ArthroCare Stock Gaps Down On Today's Open (ARTC)

ArthroCare Stock Gaps Down On Today's Open (ARTC)

Shares of ArthroCare Corporation (Nasdaq:ARTC) were gapping down Friday morning with an open price 17.1% lower than Thursday's closing price. The stock closed at $30.77 yesterday and opened today's trading at $25.52.

ArthroCare Reports Fourth Quarter And Full Year 2011 Financial Results

ArthroCare Reports Fourth Quarter And Full Year 2011 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2011, as follows: ...

ArthroCare Announces Date For Fourth Quarter And Full Year 2011 Financial Results Press Release And Conference Call

ArthroCare Announces Date For Fourth Quarter And Full Year 2011 Financial Results Press Release And Conference Call

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its fourth quarter and full year 2011 results on Thursday, February 16, 2011.

ArthroCare Announces Participation In Investor Conference

ArthroCare Announces Participation In Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

ArthroCare Announces Agreement In Principle To Settle Securities Class Action

ArthroCare Announces Agreement In Principle To Settle Securities Class Action

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that it has reached an agreement in principle to settle the private securities class action...

ArthroCare Stock Hits New 52-Week Low (ARTC)

ArthroCare Stock Hits New 52-Week Low (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) hit a new 52-week low Monday as it is currently trading at $26.20, below its previous 52-week low of $26.27 with 125,343 shares traded as of 3:09 p.m. ET. Average volume has been 150,300 shares over the past 30 days.

ArthroCare Announces Participation In Investor Conference

ArthroCare Announces Participation In Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been downgraded by TheStreet Ratings from from a buy to hold.

ArthroCare Reports Third Quarter 2011 Financial Results

ArthroCare Reports Third Quarter 2011 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the third quarter ended September 30, 2011.

ArthroCare Announces Third Quarter 2011 Financial Results Press Release And Conference Call Dates

ArthroCare Announces Third Quarter 2011 Financial Results Press Release And Conference Call Dates

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its third quarter 2011 results on Wednesday, November 2, 2011.

ArthroCare® Receives FDA Clearance For SpeedLock® Knotless Fixation Device

ArthroCare® Receives FDA Clearance For SpeedLock® Knotless Fixation Device

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.

ArthroCare Reports Second Quarter 2011 Financial Results

ArthroCare Reports Second Quarter 2011 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second quarter ended June 30, 2011 as follows: SECOND...

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been upgraded by TheStreet Ratings from a hold to buy.

ArthroCare Announces Second Quarter 2011 Financial Results Press Release And Conference Call Dates

ArthroCare Announces Second Quarter 2011 Financial Results Press Release And Conference Call Dates

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2011 results on Wednesday, August 3, 2011.

ArthroCare Receives FDA Clearance For SpeedFix™ Suture System

ArthroCare Receives FDA Clearance For SpeedFix™ Suture System

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.

ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant

ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant

ArthroCare ® Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.

ArthroCare Announces Participation In Investor Conferences

ArthroCare Announces Participation In Investor Conferences

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in two upcoming investor conferences, as detailed below.

ArthroCare Rises On Unusually High Volume (ARTC)

ArthroCare Rises On Unusually High Volume (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) is trading at unusually high volume Wednesday with 575,057 shares changing hands. It is currently at four times its average daily volume and trading up $1.32 (+4.1%).

ArthroCare Reports First Quarter 2011 Financial Results

ArthroCare Reports First Quarter 2011 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2011 as follows: FIRST...

ArthroCare Reaches New 52-Week High (ARTC)

ArthroCare Reaches New 52-Week High (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) hit a new 52-week high Friday as it is currently trading at $35.77, above its previous 52-week high of $35.56 with 15,900 shares traded as of 9:40 a.m. ET. Average volume has been 178,800 shares over the past 30 days.

ArthroCare Announces First Quarter 2011 Financial Results Press Release And Conference Call Dates

ArthroCare Announces First Quarter 2011 Financial Results Press Release And Conference Call Dates

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its first quarter 2011 results on Monday, May 2, 2011.

ArthroCare Stock Hits New 52-Week High (ARTC)

ArthroCare Stock Hits New 52-Week High (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) hit a new 52-week high Thursday as it changed hands at $34.88 compared with its previous 52-week high of $34.50. ArthroCare is currently trading at $34.62 with 39,374 shares changing hands as of 10:36 a.m..

ArthroCare Stock Hits New 52-Week High (ARTC)

ArthroCare Stock Hits New 52-Week High (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) hit a new 52-week high Wednesday as it changed hands at $34.34 compared with its previous 52-week high of $34.25. ArthroCare is currently trading at $34.08 with 10,221 shares changing hands as of 9:58 a.m..

ArthroCare Receives FDA Clearance For Parallax Contour-enhanced Vertebral Augmentation Device

ArthroCare Receives FDA Clearance For Parallax Contour-enhanced Vertebral Augmentation Device

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.

FedEx, Deere: New Targets, Estimates

FedEx, Deere: New Targets, Estimates

FedEx estimates cut at Morgan Stanley and Credit Suisse. Deere estimates, target upped at Jefferies.

ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant

ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.

ArthroCare Stock Hits New 52-Week High (ARTC)

ArthroCare Stock Hits New 52-Week High (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) hit a new 52-week high Monday as it changed hands at $33.50 compared with its previous 52-week high of $32.60. ArthroCare is currently trading at $33.45 with 22,677 shares changing hands as of 9:30 a.m..

ArthroCare Reports Fourth Quarter And Full Year 2010 Financial Results

ArthroCare Reports Fourth Quarter And Full Year 2010 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2010, as follows: ...